Navigation Links
2-Day Seminar FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials by Ex-FDA Official (Tampa, FL, United States - May 18-19, 2017) - Research and Markets
Date:4/8/2017

DUBLIN, April 7, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials: 2-Day In-Person Seminar by Ex-FDA Official" conference to their offering.

Because a phase 1 clinical trial initially introduces an investigational new drug into human subjects, appropriate CGMP help ensure subject safety. It is important to implement quality control (QC) principles to the manufacture of phase 1 investigational drugs (i.e., interpreting and implementing CGMP consistent with good scientific methodology), which foster CGMP activities that are more appropriate for phase 1 clinical trials, improve the quality of phase 1 investigational drugs, and facilitate the initiation of investigational clinical trials in humans while continuing to protect trial subjects.

The following steps to establish the appropriate manufacturing environment for phase 1 investigational drugs should be taken: 

- A comprehensive and systematic evaluation of the manufacturing setting (i.e., product environment, equipment, process, personnel, materials) to identify potential hazards
- Appropriate actions prior to and during manufacturing to eliminate or mitigate potential hazards to safeguard the quality of the phase 1 investigational drug

Review the FDA recommendations and requirements for implementing a compliant program for the phase 1 clinical program.

The following topics will be discussed to provide the foundation and basis for advancing drugs into clinical development from research and providing required information to the FDA regarding these products.

- Overview of Good Manufacturing Practices
- GMP Requirements for a Phase 1 Study
- Personnel
- QC Function
- Facility and Equipment
- Control of components, containers and closures
- Manufacturing & Records
- Laboratory Controls
- Vendor selection & management
- Process Validation
- Special Considerations
- Multi-product facilities
- Biologics
- Sterile products
- Combination products
- Providing relevant information in the IND application

Course benefit:

This workshop will review the current regulations, guidance documents for early stage manufacturing and GMPs in detail. Regulatory strategies and logistical considerations for early development stage product, including vendor selection and management, stability, labeling, and documentation requirements will also be reviewed and explored.

Learning Objectives:

To gain an understanding of the requirements for drugs entering into phase 1 clinical development and the minimum FDA requirements for phase I GMPs. To learn practical applications for implementing manufacturing and quality strategies to meet FDA requirements.

Areas Covered:

Day 1 Topics

- Overview of GMP requirements
- GMP Requirements for a Phase 1 Study
- Personnel documentation and requirements
- QC Function procedures and requirements
- Facility and Equipment requirements
- Control of components, containers and closures - methods and specs
- Manufacturing & Records during phase 1 studies with an eye toward later development

Day 2 Topics

- Vendor selection & management
- Process Validation to conduct for phase 1 clinical supply process
- Specific requirements for various types of products: biologics, combinations, sterile products
- Multi-product facilities considerations
- Preparing relevant SOPs for early stage development
- Providing relevant information in the IND application

For more information about this conference visit http://www.researchandmarkets.com/research/24fd6x/fdas_gmp

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/2-day-seminar-fdas-gmp-expectations-for-phase-i-and-first-in-man-clinical-trials-by-ex-fda-official-tampa-fl-united-states---may-18-19-2017---research-and-markets-300436530.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. ComplianceOnline Announces Seminar on Pharmacovigilance Audit Strategy Planning
2. Online Seminar on Crystallization Scale-up From METTLER TOLEDO
3. ComplianceOnline Announces Seminar on FDA Regulation of Regenerative Medicine
4. Former Senior FDA Official to Conduct Popular ComplianceOnline Seminar on the FDA’s Import Program
5. ComplianceOnline Announces Seminar on Medical Device Risk Management
6. ComplianceOnline Announces Popular Seminar on Effective Quality Oversight of Pharmaceutical CMOs
7. ComplianceOnline Announces On-Demand Seminar on Advertising and Promotional Requirements for Drugs and Medical Devices
8. ComplianceOnline Announces Seminar on Latin America: Regulatory Compliance Requirements for Life Science Products (Focus: Brazil, Mexico, Argentina)
9. ComplianceOnline Announces Seminar on Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions
10. Complimentary Educational Seminar for Keratoconus Patients at Corneal Associates of New Jersey
11. Texas Fertility Center Offers Complementary Egg Freezing Seminars
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2019)... ... May 15, 2019 , ... Milton Hershey School® has named William Charles ... within the biomedical industry, where he is changing lives by creating solutions to global ... Harding epitomizes the vision of our founders – Milton and Catherine Hershey – who ...
(Date:5/14/2019)... , ... May 14, 2019 , ... Gateway Genomics ... effectively doubling its space from 2,500 to 5,000 square feet. , “This past ... DNA tests ,” says Gateway Genomics CEO, Chris Jacob. “The SneakPeek At-Home test, which ...
(Date:5/4/2019)... ... May 03, 2019 , ... More than three ... Pesquisas Association, the scientist and ufologist Urandir Fernandes de Oliveira, last Thursday (25), ... the results of some research carried out by the association, in partnership with ...
(Date:5/2/2019)... ... 2019 , ... The centuries old practice of brewing beer thrives today across ... and even home brewing clubs scattered across the nation. , But proper beer ... can produce a superb product. Students at South Dakota School of Mines & ...
Breaking Biology Technology:
(Date:5/24/2019)... , ... May 24, 2019 , ... The newest edition ... is now available on the company’s global website. , Crystallography Times is a monthly ... X-ray diffraction. It serves the X-ray analysis community by presenting the latest news and ...
(Date:5/23/2019)... , ... May 23, 2019 , ... ... Agents for sales and service organizations, today announced its inclusion in DMG ... Solutions as the intelligent virtual agent (IVA) market share leader, based on number ...
(Date:5/21/2019)... ... May 21, 2019 , ... Experiential tourism, a trend encompassing culinary travel, ... last several years. And according to a recent report by Skift, a media ... fact, more and more travelers are wanting their journeys to be authentic and unique, ...
Breaking Biology News(10 mins):